Published in Nature on April 20, 1984
Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron (1995) 1.56
30 years of dynorphins--new insights on their functions in neuropsychiatric diseases. Pharmacol Ther (2009) 1.50
Long term plasticity of corticostriatal synapses is modulated by pathway-specific co-release of opioids through kappa-opioid receptors. J Physiol (2017) 1.08
Alcohol-induced plasticity in the dynorphin/kappa-opioid receptor system. Front Mol Neurosci (2012) 0.95
Striatal cholinergic interneuron regulation and circuit effects. Front Synaptic Neurosci (2014) 0.91
GABAergic inputs from direct and indirect striatal projection neurons onto cholinergic interneurons in the primate putamen. J Comp Neurol (2013) 0.91
Dynorphin A and cAMP-dependent protein kinase independently regulate neuronal calcium currents. Proc Natl Acad Sci U S A (1990) 0.89
The selective delta opioid agonist SNC80 enhances amphetamine-mediated efflux of dopamine from rat striatum. Neuropharmacology (2008) 0.87
Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br J Pharmacol (1991) 0.85
Cannabinoid, melanocortin and opioid receptor expression on DRD1 and DRD2 subpopulations in rat striatum. Front Neuroanat (2014) 0.85
Cholinergic interneurons in the dorsal and ventral striatum: anatomical and functional considerations in normal and diseased conditions. Ann N Y Acad Sci (2015) 0.84
Immunoneutralization of agmatine sensitizes mice to micro-opioid receptor tolerance. J Pharmacol Exp Ther (2009) 0.82
Improvement by dynorphin A (1-13) of galanin-induced impairment of memory accompanied by blockade of reductions in acetylcholine release in rats. Br J Pharmacol (1996) 0.81
Neurobiology of aversive states. Physiol Behav (2011) 0.80
Glutamate-evoked release of endogenous brain dopamine: inhibition by an excitatory amino acid antagonist and an enkephalin analogue. Br J Pharmacol (1987) 0.77
Visualization of multiple opioid-receptor types in rat striatum after specific mesencephalic lesions. Proc Natl Acad Sci U S A (1987) 0.77
Characterization of the decrease of extracellular striatal dopamine induced by intrastriatal morphine administration. Br J Pharmacol (1999) 0.75
Synaptic localization of kappa opioid receptors in guinea pig neostriatum. Proc Natl Acad Sci U S A (1992) 0.75
Isolation of murine pluripotent hemopoietic stem cells. J Exp Med (1984) 3.56
Antineutrophil cytoplasmic antibodies: a still-growing class of autoantibodies in inflammatory disorders. Am J Med (1992) 2.12
CHOP compared with CHOP plus granulocyte colony-stimulating factor in elderly patients with aggressive non-Hodgkin's lymphoma. J Clin Oncol (2003) 1.75
Synaptic biochemistry of amino acids. Fed Proc (1973) 1.74
Neutrophil activation in vitro and in vivo in Wegener's granulomatosis. Kidney Int (1994) 1.66
Drug-induced reinstatement of heroin- and cocaine-seeking behaviour following long-term extinction is associated with expression of behavioural sensitization. Eur J Neurosci (1998) 1.51
Grading of dysplasia in Barrett's oesophagus: substantial interobserver variation between general and gastrointestinal pathologists. Histopathology (2007) 1.47
Successful treatment of Kaposi's sarcoma in a renal allograft recipient. Nephrol Dial Transplant (1995) 1.41
Predictors for neoplastic progression in patients with Barrett's Esophagus: a prospective cohort study. Am J Gastroenterol (2011) 1.36
Separation and functional analysis of bone marrow cells separated by rhodamine-123 fluorescence. Exp Hematol (1987) 1.19
A single exposure to morphine induces long-lasting behavioural and neurochemical sensitization in rats. Eur J Neurosci (2001) 1.18
Interactions between CB1 cannabinoid and mu opioid receptors mediating inhibition of neurotransmitter release in rat nucleus accumbens core. Neuropharmacology (2006) 1.08
Outcome of surgical treatment of adenocarcinoma in Barrett's oesophagus. Gut (1992) 1.08
Somatostatin analogue scintigraphy in granulomatous diseases. Eur J Nucl Med (1994) 1.07
Opioid receptor-mediated inhibition of dopamine and acetylcholine release from slices of rat nucleus accumbens, olfactory tubercle and frontal cortex. Eur J Pharmacol (1990) 1.06
Morphine-induced long-term sensitization to the locomotor effects of morphine and amphetamine depends on the temporal pattern of the pretreatment regimen. Psychopharmacology (Berl) (1997) 1.06
Comparison of different polymerase chain reaction-based approaches for clonality assessment of immunoglobulin heavy-chain gene rearrangements in B-cell neoplasia. Mod Pathol (1999) 1.05
Increased dopamine release from rat striatal slices by inhibitors of GABA-aminotransferase. Eur J Pharmacol (1977) 1.05
Thymus regeneration by bone marrow cell suspensions differing in the potential to form early and late spleen colonies. Exp Hematol (1985) 1.02
Release of ACTH by substances of central nervous system origin. Endocrinology (1969) 1.01
Accumulation of p53 protein in normal, dysplastic, and neoplastic Barrett's oesophagus. J Pathol (1995) 1.00
ANCA--pathophysiology revisited. Clin Exp Immunol (1995) 0.98
In vivo somatostatin receptor imaging in medullary thyroid carcinoma. J Clin Endocrinol Metab (1993) 0.98
Neurochemical correlates of synaptically active amino acids. Life Sci (1974) 0.97
Dopaminergic mechanisms mediating the long-term expression of locomotor sensitization following pre-exposure to morphine or amphetamine. Psychopharmacology (Berl) (1999) 0.97
Accumulation of genetic abnormalities during neoplastic progression in Barrett's esophagus. Cancer Res (1995) 0.96
Transient neurologic and ocular manifestations in primary thrombocythemia. Neurology (1993) 0.96
Anti-neutrophil cytoplasmic antibodies (ANCA) in sera from patients with inflammatory bowel disease (IBD). Relation to disease pattern and disease activity. Dig Dis Sci (1994) 0.96
Vertebral bone destruction in sickle cell disease: infection, infarction or both. Neth J Med (1996) 0.95
Interferon expression in the testes of transgenic mice leads to sterility. J Biol Chem (1988) 0.93
Adenosine modulates depolarization-induced release of 3H-noradrenaline from slices of rat brain neocortex. Eur J Pharmacol (1978) 0.92
Interacting presynaptic kappa-opioid and GABAA receptors modulate dopamine release from rat striatal synaptosomes. J Neurochem (1993) 0.92
Ethanol, like psychostimulants and morphine, causes long-lasting hyperreactivity of dopamine and acetylcholine neurons of rat nucleus accumbens: possible role in behavioural sensitization. Psychopharmacology (Berl) (1997) 0.92
On the mechanism of alpha-receptor mediated modulation of 3H-noradrenaline release from slices of rat brain neocortex. Naunyn Schmiedebergs Arch Pharmacol (1977) 0.92
Antibody responses to pneumococcal and haemophilus vaccinations in patients with B-cell chronic lymphocytic leukaemia. Vaccine (2001) 0.91
Release of acetylcholine from hippocampal slices by potassium depolarization: dependence on high affinity choline uptake. Brain Res (1974) 0.91
Synergistically interacting dopamine D1 and NMDA receptors mediate nonvesicular transporter-dependent GABA release from rat striatal medium spiny neurons. J Neurosci (2000) 0.91
Kappa1- and kappa2-opioid receptors mediating presynaptic inhibition of dopamine and acetylcholine release in rat neostriatum. Br J Pharmacol (1997) 0.91
Effect of adenosine on depolarization-induced release of various radiolabelled neurotransmitters from slices of rat corpus striatum. Neuropharmacology (1979) 0.91
Differential control of Ca2+-dependent [3H]noradrenaline release from rat brain slices through presynaptic opiate receptors and alpha-adrenoceptors. Eur J Pharmacol (1983) 0.91
[3H]noradrenaline release from brain slices induced by an increase in the intracellular sodium concentration: role of intracellular calcium stores. J Neurochem (1983) 0.89
Bremazocine reduces unrestricted free-choice ethanol self-administration in rats without affecting sucrose preference. Psychopharmacology (Berl) (1999) 0.88
Correction of lysosomal enzyme deficiency in various organs of beta-glucuronidase-deficient mice by allogeneic bone marrow transplantation. Transplantation (1987) 0.88
Cyclic AMP facilitates the electrically evoked release of radiolabelled noradrenaline, dopamine and 5-hydroxytryptamine from rat brain slices. Naunyn Schmiedebergs Arch Pharmacol (1985) 0.88
Activation of presynaptic alpha-noradrenaline receptors in rat brain by the potent dopamine-mimetic N,N-dipropyl-5,6-ADTN. Eur J Pharmacol (1980) 0.88
Mu-, delta- and kappa-opioid receptor-mediated inhibition of neurotransmitter release and adenylate cyclase activity in rat brain slices: studies with fentanyl isothiocyanate. Eur J Pharmacol (1988) 0.88
Inhibitory effects of histamine on the release of serotonin and noradrenaline from rat brain slices. Neurochem Int (1991) 0.87
Cyclic somatostatin analogues as potent antagonists at mu-, but not delta- and kappa-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Eur J Pharmacol (1991) 0.87
Unrestricted free-choice ethanol self-administration in rats causes long-term neuroadaptations in the nucleus accumbens and caudate putamen. Psychopharmacology (Berl) (1999) 0.87
Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut (1994) 0.86
T lymphocytes determine the development of xeno GVHD and of human hemopoiesis in NOD/SCID mice following human umbilical cord blood transplantation. Stem Cells (1998) 0.86
Cytogenetic analysis of Barrett's mucosa and adenocarcinoma of the distal esophagus and cardia. Cancer Genet Cytogenet (1996) 0.86
Pharmacological characterization of presynaptic alpha-adrenoceptors modulating [3H]noradrenaline and [3H]5-hydroxytryptamine release from slices of the hippocampus of the rat. Eur J Pharmacol (1982) 0.86
Pharmacological profile of various kappa-agonists at kappa-, mu- and delta-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the rat brain. Br J Pharmacol (1991) 0.85
A single administration of interleukin-1 or amphetamine induces long-lasting increases in evoked noradrenaline release in the hypothalamus and sensitization of ACTH and corticosterone responses in rats. Eur J Neurosci (2001) 0.85
Ontogeny of mu-, delta- and kappa-opioid receptors mediating inhibition of neurotransmitter release and adenylate cyclase activity in rat brain. Brain Res Dev Brain Res (1990) 0.85
Modulation by histamine of the efflux of radiolabeled catecholamines from rat brain slices. Eur J Pharmacol (1977) 0.85
Calcium-dependent release of radiolabeled catecholamines and serotonin from rat brain synaptosomes in a superfusion system. Brain Res (1975) 0.85
Effect of mianserin, a potent anti-serotonin agent, on the isolated rat stomach fundus preparation. Eur J Pharmacol (1974) 0.84
Dissociable effects of the kappa-opioid receptor agonists bremazocine, U69593, and U50488H on locomotor activity and long-term behavioral sensitization induced by amphetamine and cocaine. Psychopharmacology (Berl) (2000) 0.83
Selectivity of various opioid peptides towards delta-, kappa; and mu-opioid receptors mediating presynaptic inhibition of neurotransmitter release in the brain. Neuropeptides (1989) 0.83
Lack of cross-sensitization of the locomotor effects of morphine in amphetamine-treated rats. Neuropsychopharmacology (1999) 0.83
Mifepristone prevents the expression of long-term behavioural sensitization to amphetamine. Eur J Pharmacol (1996) 0.83
Potassium-induced release of amino acids from cerebral cortex and spinal cord slices of the rat. Brain Res (1974) 0.83
Delayed occurrence of enhanced striatal preprodynorphin gene expression in behaviorally sensitized rats: differential long-term effects of intermittent and chronic morphine administration. Neuroscience (1997) 0.83
Effect of surface antigen labeling on spleen colony formation: comparison of the indirect immunofluorescence and the biotin-avidin methods. Exp Hematol (1985) 0.83
Evaluation of the benefit of routine intraoperative frozen section analysis of sentinel lymph nodes in breast cancer. ISRN Oncol (2013) 0.83
MK-801 reinstates drug-seeking behaviour in cocaine-trained rats. Neuroreport (1998) 0.82
A double-blind, placebo-controlled study of monoclonal anti-interleukin-2 receptor antibody (BT563) administration to prevent acute rejection after kidney transplantation. Transplantation (1995) 0.82
Stimulation of D2-dopamine receptors in rat neostriatum inhibits the release of acetylcholine and dopamine but does not affect the release of gamma-aminobutyric acid, glutamate or serotonin. Eur J Pharmacol (1982) 0.82
Mesangiocapillary glomerulonephritis associated with hereditary angioedema. Nephron (1995) 0.82
3H-noradrenaline release from rat neocortical slices in the absence of extracellular Ca2+ and its presynaptic alpha 2-adrenergic modulation. A study on the possible role of cyclic AMP. Naunyn Schmiedebergs Arch Pharmacol (1983) 0.82
Treatment of relapsing experimental autoimmune encephalomyelitis with largely MHC-matched allogeneic bone marrow transplantation. Transplantation (1996) 0.82
On the capacity of presynaptic alpha receptors to modulate norepinephrine release from slices of rat neocortex and the affinity of some agonists and antagonists for these receptors. J Pharmacol Exp Ther (1979) 0.82
Striatal dopamine receptors in rats displaying long-term behavioural sensitization to morphine. Synapse (1997) 0.81
A cumulative dose-response technique for the characterization of presynaptic receptors modulating [3H]noradrenaline release from rat brain slices. Eur J Pharmacol (1982) 0.81
Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol (1993) 0.81
Chronic exposure to morphine and naltrexone induces changes in catecholaminergic neurotransmission in rat brain without altering mu-opioid receptor sensitivity. Life Sci (1993) 0.81